Skip to content
lifestyle.clientim.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Conexeu Sciences Inc.
Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission
October 8, 2026
Conexeu Sciences Sets September and October 2026 Conference Schedule
September 1, 2026
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
August 19, 2026
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
June 25, 2026
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
June 8, 2026
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026
June 3, 2026
Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026
UPDATE – Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026
UPDATE – Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026
Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026